Allen C. Ho MD

Dr. Allen C. Ho is an internationally recognized retina specialist who specializes in state-of-the-art and compassionate patient care and is a leader in the development of new medical and surgical treatments for retinal disease. He is a Phi Beta Kappa graduate of Cornell University College of Arts and Sciences, receiving the highest distinction in all subjects. He graduated from Columbia University College of Physicians and Surgeons and was elected Co-Chief Resident during his ophthalmology residency at Wills Eye Hospital. He completed a Fellowship in Vitreoretinal Diseases at Manhattan Eye, Ear and Throat Hospital where he was awarded a Heed Ophthalmic Fellowship. Currently, he is an Attending Surgeon at Wills Eye Hospital and Director of Retina Research at Wills Eye Hospital. He is the former Co-Director of the Wills Retina Fellowship, widely recognized as the premier retina training program in the country. He has received the American Society of Retina Specialists’ Crystal Apple Award recognizing his mentorship of retina fellowship trainees and the American Diabetes Association Physician of the Year award. He is currently President of the Retina Society.

He is a Professor of Ophthalmology at Thomas Jefferson University School of Medicine. Dr. Ho is Editor-in-Chief of Current Opinion in Ophthalmology and Chief Medical Editor of Retina Today, a global publication that features new treatments for retinal disease. He is an invited lecturer at numerous national and international ophthalmic meetings. Dr. Ho has authored numerous scientific publications on retinal disease, is the author of The Wills Eye Hospital Color Atlas and Synopsis of Retinal Disease and Age-Related Macular Degeneration Diagnosis and Treatment, and is a member of the Editorial Review Boards of Ophthalmic Surgery Lasers and Imaging, Ocular Surgery News, and Evidence-Based Ophthalmology. Dr. Ho is the Principal Investigator at Wills Eye Hospital of several collaborative clinical trials evaluating new treatments for age-related macular degeneration and diabetic retinopathy and maintains special interests in macular diseases, diabetic retinopathy, surgical retinal diseases, and clinical trials investigating new treatments for vitreoretinal disease.